{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:20:55Z","timestamp":1783675255403,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21977006"],"award-info":[{"award-number":["21977006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["RD2022-03"],"award-info":[{"award-number":["RD2022-03"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015083","name":"Peking University People's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7252196"],"award-info":[{"award-number":["7252196"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118493","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:31:58Z","timestamp":1765668718000},"page":"118493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identification of N-tert-butyloxycarbonyl protected amino acids as novel hydrophobic tags to induce targeted protein degradation"],"prefix":"10.1016","volume":"303","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3398-8960","authenticated-orcid":false,"given":"Hui","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9193-8659","authenticated-orcid":false,"given":"Yan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118493_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100647","article-title":"Major advances in targeted protein degradation: protacs, LYTACs, and MADTACs","volume":"296","author":"Alabi","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118493_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chembiol.2024.10.004","article-title":"Next steps for targeted protein degradation","volume":"32","author":"Krone","year":"2024","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118493_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107466","article-title":"Autophagy mediated targeting degradation, a promising strategy in drug development","volume":"149","author":"Zhang","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2025.118493_bib4","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.3390\/ijms26146576","article-title":"Targeted degradation technologies utilizing autophagy","volume":"26","author":"Zhou","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2025.118493_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/acs.biochem.2c00310","article-title":"Targeted protein degradation via lysosomes","volume":"62","author":"Paudel","year":"2023","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.ejmech.2025.118493_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tips.2020.04.005","article-title":"Emerging new concepts of degrader technologies","volume":"41","author":"Ding","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118493_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41571-023-00736-3","article-title":"Protein degraders enter the clinic \u2013 a new approach to cancer therapy","volume":"20","author":"Chirnomas","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118493_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202100270","article-title":"Recent developments in PROTAC-mediated protein degradation: from bench to clinic","volume":"23","author":"Hu","year":"2022","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2025.118493_bib9","unstructured":"Clinicaltrials.Gov ID NCT06764485."},{"key":"10.1016\/j.ejmech.2025.118493_bib10","unstructured":"Clinicaltrials.Gov ID NCT06846671."},{"issue":"16","key":"10.1016\/j.ejmech.2025.118493_bib11","doi-asserted-by":"crossref","first-page":"10917","DOI":"10.1021\/acs.jmedchem.3c00736","article-title":"Small-molecule hydrophobic tagging: a promising strategy of druglike technology for targeted protein degradation","volume":"66","author":"Xie","year":"2023","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2025.118493_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/17460441.2024.2360416","article-title":"Hydrophobic tagging of small molecules: an overview of the literature and future outlook","volume":"19","author":"Zhou","year":"2024","journal-title":"Expet Opin. Drug Discov."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118493_bib13","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/nchembio.1658","article-title":"Pharmacological targeting of the pseudokinase Her3","volume":"10","author":"Xie","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"33","key":"10.1016\/j.ejmech.2025.118493_bib14","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1002\/anie.201503720","article-title":"Small-molecule-mediated degradation of the androgen receptor through hydrophobic tagging","volume":"54","author":"Gustafson","year":"2015","journal-title":"Angew. Chem., Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2025.118493_bib15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bioorg.2018.11.042","article-title":"TDP-43 specific reduction induced by Di-hydrophobic tags conjugated peptides","volume":"84","author":"Gao","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118493_bib16","doi-asserted-by":"crossref","first-page":"6407","DOI":"10.3390\/ijms22126407","article-title":"Hydrophobic tagging-mediated degradation of transcription coactivator SRC-1","volume":"22","author":"Choi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118493_bib17","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1021\/cb400569k","article-title":"A bidirectional system for the dynamic small molecule control of intracellular fusion proteins","volume":"8","author":"Neklesa","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118493_bib18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.chembiol.2012.04.008","article-title":"Inhibitor mediated protein degradation","volume":"19","author":"Long","year":"2012","journal-title":"Chem. Biol."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118493_bib19","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1021\/acschembio.6b00656","article-title":"Boc3Arg-linked ligands induce degradation by localizing target proteins to the 20S proteasome","volume":"11","author":"Shi","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118493_bib20","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1021\/acsmedchemlett.4c00274","article-title":"Identification of Boc2Lys-linked ethacrynic acid and its analogues as efficient glutathione S-transferase degraders","volume":"15","author":"Sun","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118493_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3390\/cells10010117","article-title":"Chronic myeloid leukemia: a model disease of the past, present and future","volume":"10","author":"Minciacchi","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118493_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrm1280","article-title":"Regulation of the c-Abl and Bcr\u2013Abl tyrosine kinases","volume":"5","author":"Hantschel","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118493_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4155\/fmc.10.272","article-title":"Tinkering outside the kinase ATP box: allosteric (type IV) and bivalent (type V) inhibitors of protein kinases","volume":"3","author":"Cox","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118493_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/PPO.0000000000000165","article-title":"The role of new tyrosine kinase inhibitors in chronic myeloid leukemia","volume":"22","author":"Pophali","year":"2016","journal-title":"Cancer J."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118493_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2008.06.003","article-title":"Imatinib resistance in CML","volume":"274","author":"Volpe","year":"2009","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118493_bib26","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/leu.2017.253","article-title":"Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants","volume":"31","author":"Hehlmann","year":"2017","journal-title":"Leukemia"},{"issue":"24","key":"10.1016\/j.ejmech.2025.118493_bib27","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2009-04-214221","article-title":"Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations","volume":"114","author":"M\u00fcller","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejmech.2025.118493_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1200\/JCO.2017.74.7162","article-title":"Bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia: results from the randomized BFORE Trial","volume":"36","author":"Cortes","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ejmech.2025.118493_bib29","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/ajh.27355","article-title":"Ponatinib-review of historical development, current status, and future research","volume":"99","author":"Kantarjian","year":"2024","journal-title":"Am. J. Hematol."},{"issue":"7647","key":"10.1016\/j.ejmech.2025.118493_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nature21702","article-title":"The allosteric inhibitor ABL001 enables dual targeting of BCR\u2013ABL1","volume":"543","author":"Wylie","year":"2017","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejmech.2025.118493_bib31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nchembio760","article-title":"Allosteric inhibitors of bcr-abl\u2013dependent cell proliferation","volume":"2","author":"Adri\u00e1n","year":"2006","journal-title":"Nat. Chem. Biol."},{"issue":"7280","key":"10.1016\/j.ejmech.2025.118493_bib32","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature08675","article-title":"Targeting Bcr\u2013Abl by combining allosteric with ATP-binding-site inhibitors","volume":"463","author":"Zhang","year":"2010","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ejmech.2025.118493_bib33","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrm3658","article-title":"Chaperone machines for protein folding, unfolding and disaggregation","volume":"14","author":"Saibil","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"31","key":"10.1016\/j.ejmech.2025.118493_bib34","doi-asserted-by":"crossref","first-page":"28394","DOI":"10.1074\/jbc.M502453200","article-title":"Tripeptide mimetics inhibit the 20S proteasome by covalent bonding to the active threonines","volume":"280","author":"Braun","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118493_bib35","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"issue":"27","key":"10.1016\/j.ejmech.2025.118493_bib36","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1021\/jm049486a","article-title":"Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src\/Abl kinase inhibitor with potent antitumor activity in preclinical assays","volume":"47","author":"Lombardo","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7647","key":"10.1016\/j.ejmech.2025.118493_bib37","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nature21702","article-title":"The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1","volume":"543","author":"Wylie","year":"2017","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ejmech.2025.118493_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104994","article-title":"Single amino acid-based PROTACs trigger degradation of the oncogenic kinase BCR-ABL in chronic myeloid leukemia (CML)","volume":"299","author":"Zhang","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2025.118493_bib39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.37349\/etat.2020.00023","article-title":"Novel approaches for the rational design of PROTAC linkers","volume":"1","author":"Zagidullin","year":"2020","journal-title":"Explor Target Antitumor Ther."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:53:56Z","timestamp":1781326436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425012589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"alternative-id":["S0223523425012589"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118493","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of N-tert-butyloxycarbonyl protected amino acids as novel hydrophobic tags to induce targeted protein degradation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118493"}}